Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates

International Journal of Antimicrobial Agents

Volumn 23, Issue 2, 2004, Pages 200-203

  Lautenbach, Ebbing ^a,b   Gould, Carolyn V ^a   LaRosa, Lori A ^b   Marr, Ann Marie ^b   Nachamkin, Irving ^b   Bilker, Warren B ^a,b   Fishman, Neil O ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antimicrobial resistance; Chloramphenicol; VRE

Indexed keywords

AZTREONAM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; NAFCILLIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CORRELATION ANALYSIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

EID: 0842328627     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.09.011     Document Type: Article

References (20)

1. Murray B.E. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342:2000;710-721.
2. Edmond M.B., Wallace S.E., McClish D.K., Pfaller M.A., Jones R.N., Wenzel R.P. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 29:1999;239-244.
3. Stosor V., Peterson L.R., Postelnick M., Noskin G.A. Enterococcus faecium bacteremia: does vancomycin resistance make a difference. Arch. Intern. Med. 158:1998;522-527.
4. Lautenbach E., Schuster M.G., Bilker W.B., Brennan P.J. The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus. Clin Infect Dis. 27:1998;1259-1265.
5. Ricaurte J.C., Boucher H.W., Turett G.S., Moellering R.C., Labombardi V.J., Kislak J.W. Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia. Clin Microbiol Infect. 7:2001;17-21.
6. Facklam RR, Sahm DF. Enterococcus. In: Murray PR, Baron EJ, Phaler MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology, vol. 6. Washington, D.C.: American Society for Microbiology; 1995. p. 308-14.
7. National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved standard. M7-A5. Wayne (PA): National Committee for Clinical Laboratory Standards, Document 2; 2000.
8. Armitage P. Test for linear trend in proportions and frequencies. Biometrics. 11:1955;375-386.
9. Allington D.R., Rivey M.P. Quinupristin/dalfopristin: a therapeutic review. Clin Ther. 23:2001;24-44.
10. Fung H.B., Kirschenbaum H.L., Ojofeitimi B.O. Linezolid: an oxazolidinone antimicrobial agent. Clin Ther. 23:2001;356-391.
11. Attassi K., Hershberger E., Alam R., Zervos M.J. Thrombocytopenia associated with linezolid therapy. Clin Infect Dis. 34:2002;695-698.
12. Olsen K.M., Rebuck J.A., Rupp M.E. Arthralgias and myalgias related to quinupristin-dalfopristin administration. Clin Infect Dis. 32:2001;e83-e86.
13. Herrero I.A., Issa N.C., Patel R. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N. Engl. J. Med. 346:2002;867-869.
14. McDonald L.C., Rossiter S., Mackinson C.et al. Quinupristin-dalfopristin- resistant Enterococcus faecium on chicken and in human stool specimens. N. Engl. J. Med. 345:2001;1155-1160.
15. Prober CG, Rajchgot P, Bannatyne RM, et al. Impact of chloramphenicol use on bacterial resistance in a neonatal intensive care unit. Lancet 1983;ii:158.
16. Alekshun M.N., Levy S.B. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother. 41:1997;2067-2075.
17. Lynch C., Courvalin P., Nikaido H. Active efflux of antimicrobial agents in wild-type strains of enterococci. Antimicrob Agents Chemother. 41:1997;869-871.
18. Pfaller M.A., Jones R.N., Doern G.V., Sader H.S., Kugler K.C., Beach M.L. Survey of bloodstream infections atributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. 33:1999;283-297.
19. Lautenbach E., Bilker W.B., Brennan P.J. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol. 20:1999;318-323.
20. Morgenstern H. Ecologic studies in epidemiology: concepts, principles, and methods. Ann. Rev. Public Health. 16:1995;61-81.